Literature DB >> 32506993

Macular crystalline inclusions in Sjögren-Larsson syndrome are dynamic structures that undergo remodeling.

Shaza N Al-Holou1, Edward Siefker2, Samiksha Fouzdar-Jain1,2,3, Donny W Suh1,2,3, William B Rizzo2,3.   

Abstract

BACKGROUND: Sjögren-Larsson syndrome (SLS) is a rare genetic neurocutaneous disease caused by mutations in ALDH3A2 that results in deficiency of fatty aldehyde dehydrogenase and accumulation of fatty aldehydes and alcohols. The disease is associated with ichthyosis, spasticity, and intellectual disability. Patients exhibit a characteristic retinopathy with macular crystalline inclusions that first appear in early childhood and increase with age. Once formed, the inclusions are thought to be inert and irreversible. We sought to document how the crystalline inclusions change over time.
MATERIALS AND METHODS: Serial retinal photographs of 4 SLS subjects (9-23 years old) were taken over a period of 1-3 years. Images were compared by visual inspection and analyzed using ImageJ/Fiji software to observe changes.
RESULTS: Visual inspection of retinal photographs of SLS subjects taken over time demonstrated distinctive changes in crystalline inclusions. New inclusions were formed and some established inclusions regressed. These changes were conveniently demonstrated with software-based photographic image analysis.
CONCLUSIONS: We conclude that macular inclusions in SLS are not simply inert deposits, but are dynamic structures that form over time and are subject to remodeling. This conclusion provides new insight into the interplay between the metabolic defect and retinal pathology in SLS, and raises the potential for new therapeutic approaches to reverse some aspects of the maculopathy.

Entities:  

Keywords:  ALDH3A2 ; Fatty alcohol; fatty aldehyde; image analysis; maculopathy

Mesh:

Substances:

Year:  2020        PMID: 32506993      PMCID: PMC7425776          DOI: 10.1080/13816810.2020.1776340

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  13 in total

1.  Fiji: an open-source platform for biological-image analysis.

Authors:  Johannes Schindelin; Ignacio Arganda-Carreras; Erwin Frise; Verena Kaynig; Mark Longair; Tobias Pietzsch; Stephan Preibisch; Curtis Rueden; Stephan Saalfeld; Benjamin Schmid; Jean-Yves Tinevez; Daniel James White; Volker Hartenstein; Kevin Eliceiri; Pavel Tomancak; Albert Cardona
Journal:  Nat Methods       Date:  2012-06-28       Impact factor: 28.547

2.  MorphoLibJ: integrated library and plugins for mathematical morphology with ImageJ.

Authors:  David Legland; Ignacio Arganda-Carreras; Philippe Andrey
Journal:  Bioinformatics       Date:  2016-07-13       Impact factor: 6.937

3.  Juvenile macular dystrophy associated with deficient activity of fatty aldehyde dehydrogenase in Sjögren-Larsson syndrome.

Authors:  M A Willemsen; J R Cruysberg; J J Rotteveel; A L Aandekerk; P H Van Domburg; A F Deutman
Journal:  Am J Ophthalmol       Date:  2000-12       Impact factor: 5.258

Review 4.  Crystalline retinopathy: Unifying pathogenic pathways of disease.

Authors:  Jaclyn L Kovach; Hacer Isildak; David Sarraf
Journal:  Surv Ophthalmol       Date:  2018-08-23       Impact factor: 6.048

5.  Subclinical changes in the juvenile crystalline macular dystrophy in Sjögren-Larsson syndrome detected by optical coherence tomography.

Authors:  Joris Fuijkschot; Johannes R M Cruysberg; Michèl A A P Willemsen; Jan E E Keunen; Thomas Theelen
Journal:  Ophthalmology       Date:  2007-09-12       Impact factor: 12.079

6.  Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome.

Authors:  William B Rizzo
Journal:  Expert Opin Orphan Drugs       Date:  2016-03-10       Impact factor: 0.694

7.  Lipofuscin and melanin content of the retinal pigment epithelium in a case of Sjögren-Larsson syndrome.

Authors:  S E Nilsson; S Jagell
Journal:  Br J Ophthalmol       Date:  1987-03       Impact factor: 4.638

8.  Specific changes in the fundus typical for the Sjögren-Larsson syndrome. An ophthalmological study of 35 patients.

Authors:  S Jagell; W Polland; O Sandgren
Journal:  Acta Ophthalmol (Copenh)       Date:  1980-06

Review 9.  Sjögren-Larsson syndrome: a complex metabolic disease with a distinctive ocular phenotype.

Authors:  Samiksha Fouzdar-Jain; Donny W Suh; William B Rizzo
Journal:  Ophthalmic Genet       Date:  2019-09-12       Impact factor: 1.803

10.  TrakEM2 software for neural circuit reconstruction.

Authors:  Albert Cardona; Stephan Saalfeld; Johannes Schindelin; Ignacio Arganda-Carreras; Stephan Preibisch; Mark Longair; Pavel Tomancak; Volker Hartenstein; Rodney J Douglas
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.